Barriers and facilitators to cervical cancer screening uptake among women aged 25-49: insights from a cross-sectional study in Kiambu County, Kenya

Joyce W. Gachumi; Moses Gitonga; Betsy Rono Cheriro

doi:10.18203/2394-6040.ijcmph20250609

Authors

Joyce W. Gachumi School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya
Moses Gitonga School of Health Sciences, Dedan Kimathi University of Technology, Nyeri, Kenya
Betsy Rono Cheriro School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20250609

Keywords:

Cervical cancer, Screening, Uptake, Women

Abstract

Background: Cervical cancer ranks fourth in terms of incidence and mortality among women, despite being a highly preventable disease. To prevent cervical cancer, screening is essential. This study aimed to determine the barriers and Facilitators to cervical cancer screening among women aged 25-49 in Kiambu Town, Kiambu County, Kenya.

Methods: This study employed a descriptive cross-sectional design, where qualitative and quantitative data were obtained for triangulation purposes. Participants in the study were chosen using a multi-stage sampling technique. Barriers and facilitators to cervical cancer screening were assessed using binary logistic regression and chi-square analysis. For quantitative data analysis, SPSS version 29 was utilized, and p≤0.05 was the threshold for statistical significance. Thematic analysis was used to examine the qualitative data.

Results: In this study, the uptake of cervical cancer screening was 40.2%. Shorter travel times of 1-30 minutes to the nearest hospital (OR=2.9, 95% CI: 0.130-0.753, p=0.01) and shorter waiting times of 1-30 minutes (OR=2.3, 95% CI: 0.253-1.365, p=0.04), were found to be facilitators to cervical cancer screening which increased the odds. Conversely, poor patient-friendly services (OR=7.8, 95% CI: 0.002-1.241, p=0.009) reduced the odds of cervical cancer screening.

Conclusions: This study showed suboptimal uptake of cervical cancer screening among Kiambu women. Multipronged approaches are needed to address barriers such as long travel and waiting times which could enhance cervical cancer screening uptake. These insights are critical for reducing the cervical cancer burden among women in Kenya.

Metrics

Metrics Loading ...

References

Yimer NB, Mohammed MA, Solomon K, Tadese M, Grutzmacher S, Meikena HK, et al. Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis. Public Health. 2021;195:105-11.

Agimas MC, Adugna DG, Derseh NM, Kassaw A, Kassie YT, Abate HK, et al. Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):1-13. DOI: https://doi.org/10.1186/s12889-024-18141-5

Gitonga E, Iseme R, Mutisya R, Kodhiambo M. Cervical cancer knowledge, awareness and related health behaviours amongst women of reproductive age in Kiambu County, Kenya: a cross-sectional study. Health Psychol Behav Med. 2022;10(1):1056-70. DOI: https://doi.org/10.1080/21642850.2022.2136184

Adewumi K, Nishimura H, Oketch SY, Adsul P, Huchko M. Barriers and facilitators to cervical cancer screening in western Kenya: a qualitative study. J Cancer Educ. 2021;37(4):1122. DOI: https://doi.org/10.1007/s13187-020-01928-6

Bevilacqua KG, Gottschlich A, Murchland AR, Alvarez CS, Rivera-Andrade A, Meza R. Cervical cancer knowledge and barriers and facilitators to screening among women in two rural communities in Guatemala: a qualitative study. BMC Womens Health. 2022;22(1):1–20. DOI: https://doi.org/10.1186/s12905-022-01778-y

Ncane Z, Faleni M, Pulido-Estrada G, Apalata TR, Mabunda SA, Chitha W, et al. Knowledge on Cervical Cancer Services and Associated Risk Factors by Health Workers in the Eastern Cape Province. Healthc. 2023;11(3):325. DOI: https://doi.org/10.3390/healthcare11030325

Goel K, Vasudevan L. Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States. Hum Vaccin Immunother. 2021;17(12):5390. DOI: https://doi.org/10.1080/21645515.2021.1989919

Gebreegziabher ZA, Semagn BE, Kifelew Y, Abebaw WA, Tilahun WM. Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022. BMC Public Health. 2024;24(1):1–11. DOI: https://doi.org/10.1186/s12889-024-18148-y

Organization AH. Cervical cancer in Africa Fact Sheet. 2023. Available from: https://aho.org/fact-sheets/cervical-cancer-in-africa-fact-sheet/. Accessed on 12 November 2024.

Phaiphichit J, Paboriboune P, Kunnavong S, Chanthavilay P. Factors associated with cervical cancer screening among women aged 25–60 years in Lao People’s Democratic Republic. PLoS One. 2022;17(4):e0266592. DOI: https://doi.org/10.1371/journal.pone.0266592

Yimer NB, Mohammed MA, Solomon K, Tadese M, Grutzmacher S, Meikena HK, et al. Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis. Public Health. 2021;195:105–11. DOI: https://doi.org/10.1016/j.puhe.2021.04.014

Kassa R, Irene Y, Woldetsadik E, Kidane E, Higgins M, Dejene T, et al. Survival of women with cervical cancer in East Africa: a systematic review and meta-analysis. J Obstet Gynaecol. 2023;43(2). DOI: https://doi.org/10.1080/01443615.2023.2253308

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: https://doi.org/10.3322/caac.21660

WHO. Cervical cancer. 2022. Available from: https://www.who.int/health-topics/cervical-cancer#tab=tab_1. Accessed on 12 November 2024.

Ng’Ang’A A, Nyangasi M, Nkonge NG, Gathitu E, Kibachio J, Gichangi P, et al. Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey. BMC Public Health. 2018;18(Suppl 3). DOI: https://doi.org/10.1186/s12889-018-6054-9

KDHS. Kenya Demographic and Health Survey 2022. 2022; Available from: https://dhsprogram.com/pubs/pdf/PR143/PR143.pdf. Accessed on 12 November 2024.

KNBS. 2019 Kenya Population and Housing Census: Volume II i. 2019.

Gizaw AT, El-Khatib Z, Wolancho W, Amdissa D, Bamboro S, Boltena MT, et al. Uptake of cervical cancer screening and its predictors among women of reproductive age in Gomma district, South West Ethiopia: a community-based cross-sectional study. Infect Agent Cancer. 2022;17(1):1–10. DOI: https://doi.org/10.1186/s13027-022-00455-x

Tesfaye D, Weldegebreal F, Ayele F, Dheresa M. Cervical cancer screening uptake and associated factors among Women Living with Human Immunodeficiency Virus in public hospitals, eastern Ethiopia. Front Oncol. 2023;13. DOI: https://doi.org/10.3389/fonc.2023.1249151

Dessalegn Mekonnen B. Cervical Cancer Screening Uptake and Associated Factors among HIV-Positive Women in Ethiopia: A Systematic Review and Meta-Analysis. Adv Prev Med. 2020;2020:1–10. DOI: https://doi.org/10.1155/2020/7071925

Donatus L, Nina FK, Sama DJ, Nkfusai CN, Bede F, Shirinde J, et al. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon. PAMJ. 2019;33:106. DOI: https://doi.org/10.11604/pamj.2019.33.106.16975

Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022;22(1):1–20. DOI: https://doi.org/10.1186/s12905-022-02043-y

Choi Y, Ibrahim S, Park LP, Cohen CR, Bukusi EA, Huchko MJ. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya. BMC Womens Health. 2022;22(1):1–12. DOI: https://doi.org/10.1186/s12905-022-01702-4

Nthiga A. Determinants of cervical cancer screening uptake among women in Embu County, Kenya. 2014.